Pregabalin Versus Dexmedetomidine for Delirium Treatment After Coronary Artery Bypass Grafting

PHASE4RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

May 15, 2026

Study Completion Date

May 15, 2026

Conditions
PregabalinDelirium TreatmentCoronary Artery Bypass GraftingDexmedetomidine
Interventions
DRUG

Pregabalin

Patients will receive pregabalin capsules (75 mg) every 12 h for 24 hours by nasogastric tube.

DRUG

Dexmedetomidine

Patients will receive a bolus dose of 0.4 μg/kg dexmedetomidine (over a period of 10 to 20 min)

Trial Locations (1)

Unknown

RECRUITING

Islam Morsy, Tanta

All Listed Sponsors
lead

Tanta University

OTHER